Monthly Archives: December 2003


NAMI & Eli Lilly partners in bankrupting state Medicaid budgets – NYT Sat, 20 Dec 2003 The New York Times reports that Medicaid expenditure for prescription drugs has escalated to $27.5 billion. These costs are up 19% from last year. Antipsychotic drugs, such as Eli Lilly’s Zyprexa, eat up more […]

NAMI & Eli Lilly partners in bankrupting state Medicaid budgets ...


Dr. Carl Elliott's insightful essay in SLATE:: Why do drug companies want to give money to bioethicists in the first place? In the public relations business, this approach is called "third-party strategy."

How the Drug Industry Is Branding Itself With Bioethics




NIH Expert on Safe Drug Research Seeks Whistleblower Protection Tue, 14 Dec 2004 In the wake of the Associated Press investigative report about unethical NIH-sponsored AIDS research involving infants and pregranant women Africa, and charges of misconduct by high officials at the National Institutes of Health (NIH), Senate Finance Committee […]

NIH Expert on Safe Drug Research Seeks Whistleblower Protection


Double Dipping at NIH: “the Gaming Must End” – Editorial WashPost Tue, 6 Jul 2004 Monday’s Washington Post editorial took a critical of the corrupting influence of the pharmaceutical industry on scientists at the National Institutes of Health. The agency’s “lax ethics rules, laxly enforced” has resulted in scientists “[pocketing] […]

Double Dipping at NIH: "the Gaming Must End" – Editorial ...